Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Dunn

Showing results (1081-1090 of 1,210) with videos related to

Pageof 121
Sort By:
Inflammatory Bowel Diseases|July 22, 2015
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent HospitalizationBenjamin Click, Eric J Vargas, Alyce M Anderson, et al.
Cancer|November 21, 2019
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancerAlice Y Ho, Christopher A Barker, Brittany B Arnold, et al.
Cancer Research|April 17, 2002
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancerJun Luo, Shan Zha, Wesley R Gage, et al.
Microbiome|January 17, 2018
Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's diseaseGavin M Douglas, Richard Hansen, Casey M A Jones, et al.
BMJ Oncology|June 24, 2025
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD dataHelena M Earl, Louise Hiller, Janet A Dunn, et al.
Inflammatory Bowel Diseases|October 19, 2016
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active InflammationAbhik Bhattacharya, Bhavana B Rao, Ioannis E Koutroubakis, et al.
Plos One|July 9, 2016
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyLeila Dorling, Siddhartha Kar, Kyriaki Michailidou, et al.
The New England Journal of Medicine|March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJohn P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2019
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell CarcinomaLara A Dunn, Nadeem Riaz, Matthew G Fury, et al.
British Journal of Cancer|September 18, 2008
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of lifeH M Earl, L Hiller, J A Dunn, et al.
Pageof 121

Showing results (1081-1090 of 1,210) with videos related to

Sort By:
Pageof 121
Inflammatory Bowel Diseases|July 22, 2015
Silent Crohn's Disease: Asymptomatic Patients with Elevated C-reactive Protein Are at Risk for Subsequent HospitalizationBenjamin Click, Eric J Vargas, Alyce M Anderson, et al.
Cancer|November 21, 2019
A phase 2 clinical trial assessing the efficacy and safety of pembrolizumab and radiotherapy in patients with metastatic triple-negative breast cancerAlice Y Ho, Christopher A Barker, Brittany B Arnold, et al.
Cancer Research|April 17, 2002
Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancerJun Luo, Shan Zha, Wesley R Gage, et al.
Microbiome|January 17, 2018
Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's diseaseGavin M Douglas, Richard Hansen, Casey M A Jones, et al.
BMJ Oncology|June 24, 2025
Reduced duration adjuvant trastuzumab in the treatment of patients with HER2-positive breast cancer: a meta-analysis of randomised controlled non-inferiority trials including IPD dataHelena M Earl, Louise Hiller, Janet A Dunn, et al.
Inflammatory Bowel Diseases|October 19, 2016
Silent Crohn's Disease Predicts Increased Bowel Damage During Multiyear Follow-up: The Consequences of Under-reporting Active InflammationAbhik Bhattacharya, Bhavana B Rao, Ioannis E Koutroubakis, et al.
Plos One|July 9, 2016
The Relationship between Common Genetic Markers of Breast Cancer Risk and Chemotherapy-Induced Toxicity: A Case-Control StudyLeila Dorling, Siddhartha Kar, Kyriaki Michailidou, et al.
The New England Journal of Medicine|March 19, 2004
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancerJohn P Neoptolemos, Deborah D Stocken, Helmut Friess, et al.
International Journal of Radiation Oncology, Biology, Physics|November 4, 2019
A Phase 1b Study of Cetuximab and BYL719 (Alpelisib) Concurrent with Intensity Modulated Radiation Therapy in Stage III-IVB Head and Neck Squamous Cell CarcinomaLara A Dunn, Nadeem Riaz, Matthew G Fury, et al.
British Journal of Cancer|September 18, 2008
NEAT: National Epirubicin Adjuvant Trial--toxicity, delivered dose intensity and quality of lifeH M Earl, L Hiller, J A Dunn, et al.
Pageof 121